Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Epidemiology and screening of sickle cell anemia in the Mediterranean area and in developing countries.

Amato A, Grisanti P, Mastropietro F, Lerone M, Cappabianca MP, Ponzini D, Piscitelli R.

Ig Sanita Pubbl. 2014 Jan-Feb;70(1):41-52. Review.

PMID:
24770364
2.

Premarital screening test results for β-thalassemia and sickle cell anemia trait in east Mediterranean region of Turkey.

Guler E, Garipardic M, Dalkiran T, Davutoglu M.

Pediatr Hematol Oncol. 2010 Nov;27(8):608-13. doi: 10.3109/08880018.2010.503772.

PMID:
20795773
3.

Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.

Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C.

Health Technol Assess. 2000;4(3):i-v, 1-99. Review. No abstract available.

4.

Perspective: we need a global solution.

Odame I.

Nature. 2014 Nov 13;515(7526):S10. doi: 10.1038/515S10a. No abstract available.

PMID:
25390135
5.

Screening for sickle cell hemoglobinopathy and thalassemia.

Motulsky AG.

Isr J Med Sci. 1973 Sep-Oct;9(9):1341-9. No abstract available.

PMID:
4775114
6.

Modelling the incidence of congenital rubella syndrome in developing countries.

Cutts FT, Vynnycky E.

Int J Epidemiol. 1999 Dec;28(6):1176-84.

PMID:
10661666
7.

Pitfalls of newborn screening for sickle cell anemia.

Miller DR.

Am J Dis Child. 1979 Dec;133(12):1235-6. No abstract available.

PMID:
517471
8.

Sickle cell guidelines stress screening.

Cassetta RA.

Am Nurse. 1993 Jun;25(6):9. No abstract available.

PMID:
8512153
9.

Newborn screening shows a high incidence of sickle cell anemia in Central India.

Jain DL, Sarathi V, Upadhye D, Gulhane R, Nadkarni AH, Ghosh K, Colah RB.

Hemoglobin. 2012;36(4):316-22. doi: 10.3109/03630269.2012.691434. Epub 2012 Jun 19.

PMID:
22712682
10.

Global epidemiology of haemoglobin disorders and derived service indicators.

Modell B, Darlison M.

Bull World Health Organ. 2008 Jun;86(6):480-7.

11.

Should we screen Eastern Mediterranean sickle beta-thalassemia patients for inherited thrombophilia?

Otrock ZK, Mahfouz RA, Taher AT.

J Thromb Haemost. 2005 Mar;3(3):599-600. No abstract available.

12.

Global burden of sickle cell anaemia is set to rise by a third by 2050.

Biswas T.

BMJ. 2013 Jul 23;347:f4676. doi: 10.1136/bmj.f4676. No abstract available.

PMID:
23881947
13.

Blood spot screening. Interview by Dina Leifer.

Anionwu E.

Nurs Stand. 2004 Nov 3-9;19(8):16-7. No abstract available.

PMID:
15552462
14.

Sickle cell anemia in northern Israel: screening and prevention.

Koren A, Zalman L, Palmor H, Zamir RB, Levin C, Openheim A, Daniel-Spiegel E, Shalev S, Filon D.

Isr Med Assoc J. 2009 Apr;11(4):229-34.

15.

Community control of hereditary anaemias: memorandum from a WHO meeting.

[No authors listed]

Bull World Health Organ. 1983;61(1):63-80.

16.

[Neonatal screening for sickle cell anemia: evaluation of a five-year experience in an area of northern Paris].

Ducrocq R, Benkerrou M, Brahimi L, Belloy M, Briard ML, Vilmer E, Elion J.

Arch Pediatr. 2001 May;8(5):474-80. French.

PMID:
11396106
17.

An automated system for sickle cell screening.

Loomis SJ, Go M, Kupeli L, Bartling DJ, Binder SR.

Am Clin Lab. 1990 Oct;9(13):33-40. No abstract available.

PMID:
10148251
18.

Sickle cell-point, counterpoint.

[No authors listed]

N Engl J Med. 1973 Aug 9;289(6):323-4. No abstract available.

PMID:
4718041
19.

[Neonatal detection of sickle cell disease].

Bardakdjian-Michau J.

J Gynecol Obstet Biol Reprod (Paris). 2003 Feb;32(1 Suppl):1S61-4. Review. French.

20.

Newborn screening follow-up within the lifespan context: Michigan's experience.

Grigorescu V, Kleyn MJ, Korzeniewski SJ, Young WI, Whitten-Shurney W.

Am J Prev Med. 2010 Apr;38(4 Suppl):S522-7. doi: 10.1016/j.amepre.2010.01.002.

PMID:
20331953

Supplemental Content

Support Center